SynuCa Therapeutics
Aarhus
About SynuCa Therapeutics
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly Parkinson's disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.1M
- Funding stage: Seed
- Last round: Seed (Mar 2026)
- Website: synuca.com
Industries & Categories
Medical, Neuroscience, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/synuca-therapeutics-87979 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.